Arkolith/Insider Trading/FATE/Form 4

Redmile Group, LLC

Director, 10% OwnerFATE THERAPEUTICS INC (FATE) · full profile →Form 4 · filed Dec 28, 2023
Net Buying
Open-Market Buys
$166K
Open-Market Sells
$0
Net Open-Market Flow
$166K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 26, 2023Buy(P)45K$3.72$166K13.2M
Dec 26, 2023Other(J)1.7M$3.72$6.2M13.1M
Dec 26, 2023Other(J)1.7M$3.72$6.2M13.1M

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-130203) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for FATE THERAPEUTICS INC

Build

Ask your agent about FATE insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-23-130203"
Ask your agent
Use Arkolith to summarize insider buying and selling at FATE THERAPEUTICS INC
over the last 90 days and cite the filings.